Is the tide turning for Shield Therapeutics? Shield is a rarity for AIM: a drug development company that has hit a home run, meaning it has successfully developed a commercial ...
This Is Money
3 days ago
NatWest setback as Labour kiboshes 'Tell Sid' share sale
Business Insider via Yahoo
Tesla earnings recap: Elon Musk failed to reassure investors after Robotaxi delay and profit miss
6 days ago
Forbes
Google Stock Could Rise On Q2 Cloud Growth Despite Busted Wiz Deal
7 days ago
50 of the best funds and investment trusts: Our experts' top ideas
5 days ago
The Forex Market
Economic resilience and market rebound amid mixed signals
4 days ago
View all